Rubius Therapeutics to Present Initial Clinical Results from the Ongoing Phase 1/2 Clinical Trial of RTX-240 in Advanced Solid Tumors at the American Association of Cancer Research Virtual Annual Meeting
CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical…
New Global Expansion Report Benchmarks the Hidden Costs and Risks of Scaling Across 19 Markets
cside Launches AI Agent Detection Toolkit, Enabling Websites to Block Agentic Attackers and Guide Agentic Shoppers
Everest Medicines Announces Exclusive License Agreement with Micot to Commercialize MT1013
Banle Group Hosts Inaugural ESG Forum with Industry Leaders, Pioneering Green Shipping Solutions Amid Global Decarbonization Push